PRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Primerica Inc (PRI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, hedge fund buying trends, and positive technical indicators outweigh the lack of recent news and mixed analyst ratings. The current pre-market price of $272.5 offers a reasonable entry point for long-term growth.
The MACD is positively expanding with a histogram value of 2.417, indicating bullish momentum. The RSI is at 83.115, signaling an overbought condition, but this is not a major concern for long-term investors. The stock is trading near its R1 resistance level of 272.694, with the next resistance at 278.652. Moving averages are converging, suggesting potential for further upward movement.
Hedge funds are significantly increasing their buying activity, with a 2734.84% increase in the last quarter.
Strong financial performance in Q4 2025, with revenue up 8.32% YoY, net income up 17.98% YoY, and EPS up 23.34% YoY.
Bullish MACD and converging moving averages indicate potential for continued price growth.
RSI indicates overbought conditions, which could lead to short-term price corrections.
Analysts have mixed ratings, with some expressing concerns about industry-wide valuation pressures and competition.
No recent news or significant insider trading trends to act as immediate positive catalysts.
In Q4 2025, Primerica reported strong financial growth: revenue increased by 8.32% YoY to $853.7 million, net income rose by 17.98% YoY to $196.4 million, and EPS grew by 23.34% YoY to 6.13. These metrics indicate robust operational performance and profitability.
Analysts have mixed views on Primerica. Keefe Bruyette re-initiated coverage with a Market Perform rating and a $290 price target, citing mixed fundamentals in the life insurance sector. Morgan Stanley lowered its price target to $285 from $292, maintaining an Equal Weight rating, while TD Cowen raised its price target to $326, maintaining a Buy rating. The consensus reflects cautious optimism with some concerns about industry-wide pressures.
